/Investor DB

Intuitive Ventures — 2022 Investments

4 investments dated 2022 · listed companies and verified rows first · show all

MedCryptmedcrypt.comin𝕏Series B · Nov 2022 · $25M✓ verified

Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure their devices are secure by design and meet FDA regulatory requirements.

CybersecurityHealthtechMedical DevicesSaaSSan Diego, US

Eric Pancoast(CTO)inMike Kijewski(CEO)inVidya Murthy(VP of Operations)inWilliam Fenstermaker(Founder)Om Mahida(Engineer)Erin Murphree(talent acquisition)

Co-investorsEniac VenturesY CombinatorSection 32Alumni VenturesAnzu PartnersDolby Family Ventures+10 more

Neocisneocis.comin𝕏Oct 2022 · $40M✓ verified

Neocis develops Yomi, a robotic surgical platform that assists clinicians during dental implant surgery with planning, surgical, and restorative software features.

HealthtechMedical DevicesRoboticsMiami, US

Alon Mozes(Founder)inJuan Salcedo(Founder)inDennis Moses(Chief Technical Officer)inAndres Carrillo(VP of Product)inJorge Fernandes(VP of Quality & Regulatory)inGabe Goldberg(VP of Marketing)in

Co-investorsNorwest Venture PartnersVivo CapitalCLI VenturesFlorida Opportunity FundMithril Capital ManagementNVIDIA+5 more

Optellumoptellum.comSeries A · Sep 2022 · $14M

Optellum builds an AI-powered platform for early lung cancer diagnosis, helping thoracic care teams and health systems discover, track, and assess the malignancy risk of lung nodule patients.

AI & Machine LearningHealthtechMedical Devices

Co-investorsBlack Opal VenturesIQ CapitalMercia VenturesOutsized Ventures

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

SURGE Therapeutics

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.